Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects

Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects

Hepatocellular carcinoma (HCC) is the most prevalent primary liver cancer with poor prognosis. Surgery, chemotherapy, and radiofrequency ablation are three conventional therapeutic options that will help only a limited percentage of HCC patients. Cancer immunotherapy has achieved dramatic advances i...

Full description

Bibliographic Details
Main Authors: Zhuoyan Liu, Xuan Liu, Jiaxin Liang, Yixin Liu, Xiaorui Hou, Meichuan Zhang, Yongyin Li, Xiaotao Jiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Immunology
Subjects:
immunotherapy
hepatocellular carcinoma
HCC
immune checkpoint inhibitors
adoptive cell therapy
vaccine
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.765101/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.765101/full

Similar Items